Role of circulating tumor cell clusters in patients with metastatic hormone-sensitive prostate cancer receiving a gonadotropin-releasing hormone antagonist: A pilot study
Asian J Urol
.
2023 Apr;10(2):210-212.
doi: 10.1016/j.ajur.2022.03.009.
Epub 2022 Jul 22.
Authors
Yuki Kohada
1
2
,
Hiroki Kusumoto
1
,
Takashi Kukimoto
1
,
Jotaro Mikami
1
,
Jun Ito
1
,
Katsutoshi Asano
3
,
Toru Yaegashi
3
,
Kanichi Nakagawara
3
,
Jun Teishima
2
,
Yasuhiro Kaiho
1
,
Nobuyuki Hinata
2
,
Yasuhiro Nakamura
4
,
Makoto Sato
1
Affiliations
1
Division of Urology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
2
Department of Urology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan.
3
Nihon Gene Research Laboratories Inc, Sendai, Japan.
4
Division of Pathology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
PMID:
36942117
PMCID:
PMC10023524
DOI:
10.1016/j.ajur.2022.03.009
No abstract available